BioMarin Pharmaceutical (BMRN) Finalizes the Acquisition of Inozyme Pharma

finance.yahoo.com/news/biomarin-pharmaceutical-bmrn-finalizes-acquisition-120820338.html

In This Article:
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On July 1, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced the finalization of its acquisition of Inozyme Pharma, Inc.
The deal is valued at $270…

This story appeared on finance.yahoo.com, 2025-07-10 12:08:20.
The Entire Business World on a Single Page. Free to Use →